These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 18428534)

  • 21. Agonist potency ratios at m1 and m3 muscarinic receptors expressed in A9L and CHO cells.
    Richards MH
    Ann N Y Acad Sci; 1997 May; 812():165. PubMed ID: 9214278
    [No Abstract]   [Full Text] [Related]  

  • 22. M1 receptor agonism, a possible treatment for cognitive deficits in schizophrenia.
    Dean B
    Neuropsychopharmacology; 2004 Aug; 29(8):1583-4; author reply 1585-6. PubMed ID: 15266348
    [No Abstract]   [Full Text] [Related]  

  • 23. On the unique binding and activating properties of xanomeline at the M1 muscarinic acetylcholine receptor.
    Christopoulos A; Pierce TL; Sorman JL; El-Fakahany EE
    Mol Pharmacol; 1998 Jun; 53(6):1120-30. PubMed ID: 9614217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antagonist binding in the rat muscarinic receptor A study by docking and X-ray crystallography.
    Tanczos AC; Palmer RA; Potter BS; Saldanha JW; Howlin BJ
    Comput Biol Chem; 2004 Dec; 28(5-6):375-85. PubMed ID: 15556478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ratiometric Ca+2 measurement in human recombinant muscarinic receptor subtypes using the Flexstation scanning fluorometer.
    Gupta S; Singh RK; Nanda K; Chatterjee M; Tiwari A; Sundaram S; Gupta D; Chugh A; Dastidar S; Ray A
    J Recept Signal Transduct Res; 2009; 29(2):100-6. PubMed ID: 19288301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholinergic impact on neuroplasticity drives muscarinic M1 receptor mediated differentiation into neurons.
    Benninghoff J; Rauh W; Brantl V; Schloesser RJ; Moessner R; Möller HJ; Rujescu D
    World J Biol Psychiatry; 2013 Apr; 14(3):241-6. PubMed ID: 22022845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A fluorescence anisotropy assay for the muscarinic M1 G-protein-coupled receptor.
    Huwiler KG; De Rosier T; Hanson B; Vogel KW
    Assay Drug Dev Technol; 2010 Jun; 8(3):356-66. PubMed ID: 20233092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual effects of muscarinic M(2) acetylcholine receptors on the synthesis of cyclic AMP in CHO cells: dependence on time, receptor density and receptor agonists.
    Michal P; Lysíková M; Tucek S
    Br J Pharmacol; 2001 Mar; 132(6):1217-28. PubMed ID: 11250872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cysteine pairs in the third intracellular loop of the muscarinic m1 acetylcholine receptor play a role in agonist-induced internalization.
    Sawyer GW; Ehlert FJ; Shults CA
    J Pharmacol Exp Ther; 2008 Jan; 324(1):196-205. PubMed ID: 17540859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ligand specific up-regulation of a Renilla reniformis luciferase-tagged, structurally unstable muscarinic M3 chimeric G protein-coupled receptor.
    Zeng FY; McLean AJ; Milligan G; Lerner M; Chalmers DT; Behan DP
    Mol Pharmacol; 2003 Dec; 64(6):1474-84. PubMed ID: 14645678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional comparison of muscarinic partial agonists at muscarinic receptor subtypes hM1, hM2, hM3, hM4 and hM5 using microphysiometry.
    Wood MD; Murkitt KL; Ho M; Watson JM; Brown F; Hunter AJ; Middlemiss DN
    Br J Pharmacol; 1999 Apr; 126(7):1620-4. PubMed ID: 10323594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological assessment of m1 muscarinic acetylcholine receptor-gq/11 protein coupling in membranes prepared from postmortem human brain tissue.
    Salah-Uddin H; Thomas DR; Davies CH; Hagan JJ; Wood MD; Watson JM; Challiss RA
    J Pharmacol Exp Ther; 2008 Jun; 325(3):869-74. PubMed ID: 18322150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uncoupling of M1 muscarinic receptor/G-protein interaction by amyloid β(1-42).
    Janíčková H; Rudajev V; Zimčík P; Jakubík J; Tanila H; El-Fakahany EE; Doležal V
    Neuropharmacology; 2013 Apr; 67():272-83. PubMed ID: 23206502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Muscarinic presynaptic modulation in GABAergic pallidal synapses of the rat.
    Hernández-Martínez R; Aceves JJ; Rueda-Orozco PE; Hernández-Flores T; Hernández-González O; Tapia D; Galarraga E; Bargas J
    J Neurophysiol; 2015 Feb; 113(3):796-807. PubMed ID: 25392165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The predicted 3D structures of the human M1 muscarinic acetylcholine receptor with agonist or antagonist bound.
    Peng JY; Vaidehi N; Hall SE; Goddard WA
    ChemMedChem; 2006 Aug; 1(8):878-90. PubMed ID: 16902941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A specific multi-nutrient formulation enhances M1 muscarinic acetylcholine receptor responses in vitro.
    Savelkoul PJ; Janickova H; Kuipers AA; Hageman RJ; Kamphuis PJ; Dolezal V; Broersen LM
    J Neurochem; 2012 Feb; 120(4):631-40. PubMed ID: 22146060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rational design of partial agonists for the muscarinic m1 acetylcholine receptor.
    Chen X; Klöckner J; Holze J; Zimmermann C; Seemann WK; Schrage R; Bock A; Mohr K; Tränkle C; Holzgrabe U; Decker M
    J Med Chem; 2015 Jan; 58(2):560-76. PubMed ID: 25478907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monitoring Intracellular Calcium in Response to GPCR Activation: Comparison Between Microtiter Plates and Microfluidic Assays.
    Martins SAM; Prazeres DMF; Chu V; Conde JP
    Methods Mol Biol; 2021; 2268():289-304. PubMed ID: 34085276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pirenzepine promotes the dimerization of muscarinic M1 receptors through a three-step binding process.
    Ilien B; Glasser N; Clamme JP; Didier P; Piemont E; Chinnappan R; Daval SB; Galzi JL; Mely Y
    J Biol Chem; 2009 Jul; 284(29):19533-43. PubMed ID: 19451648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A multiplex calcium assay for identification of GPCR agonists and antagonists.
    Liu K; Southall N; Titus SA; Inglese J; Eskay RL; Shinn P; Austin CP; Heilig MA; Zheng W
    Assay Drug Dev Technol; 2010 Jun; 8(3):367-79. PubMed ID: 20230302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.